Eli Lilly and Co.’s top rising-star drug has been OK’d by U.S. regulators for a new use, an event that could boost sales of the medication. Alimta, a lung cancer drug, was approved as a maintenance therapy for non-small cell lung cancer for certain patients, Lilly announced today. The approval by the U.S. Food and […]
Once again, Indianapolis-based Eli Lilly and Co. is running in the lead pack in dollars spent to bend ears on Capitol Hill. And that was even before the health care reform debate got rolling.
The Indiana Minority Supplier Development Council has made life sciences companies its latest target—part of an even larger effort to attract minorities to the burgeoning life sciences industry under
way on a national scale.
As one of the city’s most prominent minority business owners, Bill Mays built his chemical distributorship largely on the backs of domestic automakers. In 1980,when he founded Mays Chemical Co. Inc., the Big Three accounted for nearly 75 percent of all new-car sales. But that number has dwindled to less than half of all new […]
Once again Eli Lilly and Co. is running in the lead pack in dollars spent to bend ears on Capitol Hill. And that was even before the health care reform debate got rolling. Through the first quarter, the Indianapolis-based drugmaker was on pace to break the record amount of lobbying it did last year, when it […]
Lawmakers must take action but also ensure that any plan incorporates four basic principles.
A new communications post at Eli Lilly gives former mayor Bart Peterson an opportunity to meld his experiences in the public
and private sectors.
After decades of talk about health care reform, the country seems poised to take a major step in that direction. Various bills are being filed in Congress, and President Obama has said he wants legislation on his desk by November. The momentum that’s building is driven not just by the president but by the growing […]
Former Mayor Bart Peterson outlines the pitch Eli Lilly will make in D.C. For the first time in 15 years, lawmakers in Washington have plunged into a debate about overhauling the nation’s health care system. New proposals come out every week, with bills filed in Congress running longer than 600 pages and 10-year cost estimates […]
The past decade has often been rough for Eli Lilly and Co., but a new economic impact study commissioned by the company suggests the drugmaker’s contribution to the state’s economy actually has increased over that time. The study by Indiana University professor Bruce Jaffee calculates that Lilly accounts for $8 billion, or 3.3 percent, of […]
Indianapolis has always had Eli Lilly and Co., it seems, and Lilly always seems to care for Indianapolis
like a rich uncle.
People employed directly by Lilly and by companies doing business with Lilly account for about one of every
30…
The past decade has often been rough for Eli Lilly and Co., but a new economic impact study commissioned by the company suggests the drugmaker’s contribution to the state’s economy has actually increased over that time. The new study by an Indiana University professor calculates that Lilly accounts for $8 billion, or 3.3 percent, of […]
President Barack Obama today welcomed the pharmaceutical industry’s agreement to help close a gap in Medicare’s drug coverage, calling the pact a step forward in the push for an overhaul of the nation’s health care system. Obama said that drug companies have pledged to spend $80 billion over the next decade to help reduce the […]
An exaggerated share of the nation’s wealth is paid to CEOs of public companies, their minions and directors, through agreements
made inside boardrooms, by highly compensated individuals who commit shareholders’ money and are not subject to effective
oversight.
Two chemistry professors at IUPUI are laboring to create the McDonald’s of research laboratories—a model that’s low-cost
and can spread around the world.
Businesses all want to see reform of the health care system, but they diverge on how much the U.S. government’s entrance into
the insurance market would help or hurt them.
Hope and fear mix in Paul Nysewander when he considers President Barack Obama’s controversial idea to set up a new governmentrun health insurance plan. The owner of a three-person accounting firm, Nysewander says there’s significant appeal in having a public plan as a new option for health insurance. “As long as it remains an option,” […]
Beaverton, Ore.-based athletic footwear and apparel maker Nike Inc. said today it named Eli Lilly and Co. CEO John C. Lechleiter to its board of directors. Lechleiter, 55, was named president and CEO of Indianapolis-based Eli Lilly in 2008 and became chairman of the board in 2009. “John’s combination of executive leadership and expertise leading […]
Two chemistry professors at IUPUI are laboring to create the McDonald’s of research laboratories – low-cost and all over the world. Bill Scott and Martin O’Donnell have started a project called Distributed Drug Discovery, trying to lure in researchers and students at universities around the globe to collaborate over the Internet to discover new drugs. […]
Eli Lilly and Co. has launched a Web portal to help it more easily find, evaluate and possibly license experimental drugs discovered by researchers at universities and biotechnology companies, the Indianapolis-based drugmaker announced today. Lilly hopes the program behind the portal, called the Lilly Phenotypic Drug Discovery Initiative, or PD2, opens up an untapped source […]
